BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16772982)

  • 1. Topical treatment of nasal keratoacanthoma.
    Denkler K; Kivett WF
    Plast Reconstr Surg; 2006 Jun; 117(7):2516-7. PubMed ID: 16772982
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin.
    Barysch MJ; Kamarashev J; Lockwood LL; Dummer R
    J Dermatol; 2011 Apr; 38(4):390-2. PubMed ID: 21544945
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical imiquimod for the treatment of keratoacanthomas.
    Calista D; Morri M
    Eur J Dermatol; 2008; 18(5):590-1. PubMed ID: 18779106
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical imiquimod in the treatment of large facial keratoacanthomas.
    Cecchi R; Bartoli L; Brunetti L; Pavesi M
    G Ital Dermatol Venereol; 2012 Oct; 147(5):505-7. PubMed ID: 23007258
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream.
    Di Lernia V; Ricci C; Albertini G
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):626-9. PubMed ID: 15324413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guess what! Keratoacanthoma treated with intralesional bleomycin.
    Andreassi A; Pianigiani E; Taddeucci P; Lorenzini G; Fimiani M; Biagioli M
    Eur J Dermatol; 1999; 9(5):403-5. PubMed ID: 10484668
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical treatment with imiquimod may induce regression of facial keratoacanthoma.
    Dendorfer M; Oppel T; Wollenberg A; Prinz JC
    Eur J Dermatol; 2003; 13(1):80-2. PubMed ID: 12609789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative management of recurrent nasal squamous papilloma with topical immunomodulators.
    Karkos PD; Fika Z; Benton J; Assimakopoulos DA
    Clin Otolaryngol; 2007 Jun; 32(3):222-3. PubMed ID: 17550531
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of keratoacanthoma centrifugum marginatum with local application of imiquimod cream.
    Aroni K; Mastoraki A; Agrogiannis G; Ioannidis E; Patsouris E
    Int J Dermatol; 2007 Dec; 46(12):1321-2. PubMed ID: 18173541
    [No Abstract]   [Full Text] [Related]  

  • 10. Imiquimod as a possible treatment for keratoacanthoma.
    Bhatia N
    J Drugs Dermatol; 2004; 3(1):71-4. PubMed ID: 14964750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of topical imiquimod cream on keratoacanthoma: A retrospective single-center study.
    Lee JW; Cho KH; Choi CW; Jo SJ
    J Am Acad Dermatol; 2022 Sep; 87(3):671-674. PubMed ID: 34474080
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream.
    Peris K; Micantonio T; Fargnoli MC
    Eur J Dermatol; 2003; 13(4):413-4; author reply 415. PubMed ID: 12948930
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of primary cutaneous follicle centre lymphoma with topical 5% imiquimod.
    Stavrakoglou A; Brown VL; Coutts I
    Br J Dermatol; 2007 Sep; 157(3):620-2. PubMed ID: 17553050
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of giant keratoacanthoma with intralesional 5-fluorouracil.
    Leonard AL; Hanke CW
    J Drugs Dermatol; 2006 May; 5(5):454-6. PubMed ID: 16703783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant keratoacanthoma of the nose.
    Rapaport J
    Arch Dermatol; 1975 Jan; 111(1):73-5. PubMed ID: 47238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratoacanthoma associated with the use of topical imiquimod.
    Campalani E; Holden CA
    Clin Exp Dermatol; 2013 Jul; 38(5):555-6. PubMed ID: 23777499
    [No Abstract]   [Full Text] [Related]  

  • 17. Imiquimod as neoadjuvant treatment for giant keratoacanthoma arising on a background of lupus vulgaris.
    Tsikeloudi M; Lallas A; Sidiropoulos T; Chasioti V; Lefaki I; Apalla Z
    Clin Exp Dermatol; 2014 Jan; 39(1):60-2. PubMed ID: 23773180
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical imiquimod to treat recurrent breast cancer.
    Hengge UR; Roth S; Tannapfel A
    Breast Cancer Res Treat; 2005 Nov; 94(1):93-4. PubMed ID: 16172790
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic side effects from topical imiquimod.
    Hanger C; Dalrymple J; Hepburn D
    N Z Med J; 2005 Oct; 118(1223):U1682. PubMed ID: 16224506
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrent invasive basal cell carcinoma after radiation and imiquimod: a case report.
    Wagamon K; Li LJ
    Dermatol Surg; 2007 Jan; 33(1):117-9. PubMed ID: 17214692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.